Plant ID: NPO24916
Plant Latin Name: Aristolochia debilis
Taxonomy Genus: Aristolochia
Taxonomy Family: Aristolochiaceae
NCBI TaxonomyDB:
158541
Plant-of-the-World-Online:
92883-1
Alterative; Anodyne; Antibacterial; Antifungal; Antiinflammatory; Antitussive; Carminative; Cytotoxic; Diuretic; Expectorant; Hypotensive; Stomachic; Tonic
Japan; China
TRPA1; | |
MAPK1; CDK2; | |
CA2; CA3; CA7; CA5A; CA4; CA6; CA12; CA1; CA9; CA5B; CA14; | |
ESR2; | |
PTGS1; | |
USP2; | |
MAPT; HTT; | |
SMN1;SMN2; |
Cytochrome P450 Enzymes: | CYP3A4; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | USP2 | Ubiquitin carboxyl-terminal hydrolase 2 | O75604 | CHEMBL1293227 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA4 | Carbonic anhydrase IV | P22748 | CHEMBL3729 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA5B | Carbonic anhydrase VB | Q9Y2D0 | CHEMBL3969 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Methyl-lysine/arginine binding protein | SMN1;SMN2 | Survival motor neuron protein | Q16637 | CHEMBL1293232 |
Nuclear hormone receptor subfamily 3 group A | ESR2 | Estrogen receptor beta | Q92731 | CHEMBL242 |
Oxidoreductase | PTGS1 | Cyclooxygenase-1 | P23219 | CHEMBL221 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Protein Kinase | CDK2 | Cyclin-dependent kinase 2 | P24941 | CHEMBL301 |
Transient receptor potential channel | TRPA1 | Transient receptor potential cation channel subfamily A member 1 | O75762 | CHEMBL6007 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 3.168E-10 | 6.272E-07 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 2.754E-31 | 5.997E-27 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 3.712E-06 | 4.255E-03 | CA2, CA7 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.524E-24 | 1.659E-20 | CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 8.148E-23 | 4.435E-19 | CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 1.852E-05 | 1.833E-02 | CA1, CA2 |
CC | GO:0043226; organelle | GO:0015030; Cajal body | 2.733E-05 | 2.588E-02 | CDK2, SMN1, SMN2 |
BP | GO:0050896; response to stimulus | GO:0006979; response to oxidative stress | 3.522E-05 | 3.195E-02 | CA3, CDK2, MAPK1, PTGS1, TRPA1 |
BP | GO:0051179; localization | GO:2001225; regulation of chloride transport | 5.542E-05 | 4.827E-02 | CA2, CA7 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.701E-30 | 1.888E-28 | CA12, CA1, CA3, CA5B, CA2, CA5A, CA4, CA7, CA6, CA9, CA14 |
09150 Organismal Systems | 09155 Excretory system | hsa04964 | Proximal tubule bicarbonate reclamation | 2.882E-04 | 1.599E-02 | CA2, CA4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 2.818E-03 | 7.820E-02 | MAPK1, ESR2 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 4.269E-03 | 8.330E-02 | CDK2, MAPK1 |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.741E-03 | 7.820E-02 | CA2, CYP3A4 |
09150 Organismal Systems | 09152 Endocrine system | hsa04914 | Progesterone-mediated oocyte maturation | 5.150E-03 | 8.330E-02 | CDK2, MAPK1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04915 | Estrogen signaling pathway | 5.253E-03 | 8.330E-02 | MAPK1, ESR2 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 6.673E-03 | 8.876E-02 | MAPK1, PTGS1 |
09150 Organismal Systems | 09151 Immune system | hsa04611 | Platelet activation | 7.871E-03 | 8.876E-02 | MAPK1, PTGS1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04114 | Oocyte meiosis | 7.996E-03 | 8.876E-02 | CDK2, MAPK1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; |
I00-I99: Diseases of the circulatory system | High blood pressure | I10-I16 | CA2; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Insomnia | F51.0, G47.0 | CA2; |
NA: NA | Edema | NA | CA2; |
I00-I99: Diseases of the circulatory system | Edema associated with congestive heart failure | I50, R60.9 | CA2; |
K00-K95: Diseases of the digestive system | Duodenal ulcers | K25-K27 | CA2; |
H00-H59: Diseases of the eye and adnexa | Open-angle glaucoma | H40-H42 | CA2; |